Company news
Atara Biotherapeutics, Inc. news in 2023
Atara Biotherapeutics, Inc.'s news releases, calls and decks from 2023, newest first.
Atara Biotherapeutics Announces Closing of Expanded Global Tab-cel® Partnership with Pierre Fabre Laboratories
December 19, 2023
Atara Biotherapeutics Presents Positive Preclinical Data on ATA3431, A Next-Generation Allogeneic CD20/CD19-Targeted CAR, at the 65th ASH Annual Meeting
December 10, 2023
Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 30, 2023
Atara Biotherapeutics To Present Positive New Tab-cel® Clinical Data During Oral Session at ESMO Immuno-Oncology Annual Congress 2023
November 28, 2023
Atara Biotherapeutics to Participate at the 6th Annual Evercore ISI HealthCONx Conference
November 21, 2023
Atara Biotherapeutics To Participate at the Stifel Healthcare Conference
November 9, 2023
Atara Biotherapeutics Announces Primary Analysis Data from Phase 2 EMBOLD Clinical Trial of ATA188 in Non-Active Progressive Multiple Sclerosis
November 7, 2023
Atara Biotherapeutics Announces Expanded Global Tab-cel® Partnership with Pierre Fabre Laboratories and Third Quarter 2023 Financial Results
October 31, 2023
Atara Biotherapeutics Announces Plans to Submit Tab-cel® BLA in Q2 2024 Following FDA Agreement on Comparability
September 18, 2023
Atara Biotherapeutics to Participate in Cell Therapies in Autoimmune Panel Discussion at the Citi 18th Annual BioPharma Conference
August 30, 2023
Atara Biotherapeutics Announces Second Quarter 2023 Financial Results and Operational Progress
August 7, 2023
Atara Biotherapeutics to Announce Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
July 31, 2023
Atara Biotherapeutics to Participate in the Canaccord Genuity 43rd Annual Growth Conference
July 30, 2023
Atara Biotherapeutics to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
June 6, 2023
Atara Biotherapeutics Presents Updated Tab-cel® Clinical Effectiveness Data at ASCO 2023
June 4, 2023
Atara Biotherapeutics Announces First Quarter 2023 Financial Results and Operational Progress
May 7, 2023
Atara Biotherapeutics to Announce First Quarter 2023 Financial Results on Monday, May 8, 2023
April 30, 2023
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Operational Progress
February 7, 2023
Atara Biotherapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on Wednesday, February 8, 2023
February 5, 2023
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 2, 2023
Atara Biotherapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 12, 2023